Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Dutasteride 0.02 mg	185
Overall Study	STARTED	Dutasteride 0.1 mg	188
Overall Study	STARTED	Dutasteride 0.5 mg	184
Overall Study	STARTED	Finasteride 1 mg	179
Overall Study	STARTED	Placebo	181
Overall Study	COMPLETED	Dutasteride 0.02 mg	156
Overall Study	COMPLETED	Dutasteride 0.1 mg	154
Overall Study	COMPLETED	Dutasteride 0.5 mg	153
Overall Study	COMPLETED	Finasteride 1 mg	141
Overall Study	COMPLETED	Placebo	157
Overall Study	NOT COMPLETED	Dutasteride 0.02 mg	29
Overall Study	NOT COMPLETED	Dutasteride 0.1 mg	34
Overall Study	NOT COMPLETED	Dutasteride 0.5 mg	31
Overall Study	NOT COMPLETED	Finasteride 1 mg	38
Overall Study	NOT COMPLETED	Placebo	24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01231607/flow